Mauro Panteghini

Q: What Schools Are Affiliated With Mauro Panteghini

Mauro Panteghini is affiliated with the following schools: Uppsala University, University of Milan

Mauro Panteghini's AcademicInfluence.com Rankings

Mauro Panteghini

Economics

#2851

World Rank

#3240

Historical Rank

Microeconomics

#92

World Rank

#97

Historical Rank

Macroeconomics

#236

World Rank

#250

Historical Rank

economics Degrees

Download Badge

Economics

Mauro Panteghini's Degrees

PhD Economics University of Milan
Masters Economics University of Milan
Bachelors Economics University of Milan

Similar Degrees You Can Earn

Why Is Mauro Panteghini Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Mauro Panteghini's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. (2006) (1160)
Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. (2005) (467)
Evaluation of imprecision for cardiac troponin assays at low-range concentrations. (2004) (394)
National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes. (2007) (376)
Defining analytical performance specifications: Consensus Statement from the 1st Strategic Conference of the European Federation of Clinical Chemistry and Laboratory Medicine (2015) (346)
Multicenter analytical evaluation of a high-sensitivity troponin T assay. (2011) (338)
Consensus Statement on the Worldwide Standardization of the Hemoglobin A1C Measurement (2007) (334)
Multicenter Evaluation of a 0-Hour/1-Hour Algorithm in the Diagnosis of Myocardial Infarction With High-Sensitivity Cardiac Troponin T. (2016) (288)
IFCC Primary Reference Procedures for the Measurement of Catalytic Activity Concentrations of Enzymes at 37°C. Part 4. Reference Procedure for the Measurement of Catalytic Concentration of Alanine Aminotransferase (2002) (226)
Quality Specifications for Cardiac Troponin Assays (2001) (218)
Reference intervals for serum creatinine concentrations: assessment of available data for global application. (2008) (207)
Biochemical markers for prediction of chemotherapy-induced cardiotoxicity: systematic review of the literature and recommendations for use. (2008) (204)
Quality specifications for B-type natriuretic peptide assays. (2005) (187)
IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. International Federation of Clinical Chemistry and Laboratory Medicine. Part 4. Reference procedure for the measurement of catalytic concentration of alanine aminotransferase. (2002) (185)
Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis: a systematic review (2013) (166)
Role and importance of biochemical markers in clinical cardiology. (2004) (160)
Reference intervals: the way forward (2009) (154)
IFCC Primary Reference Procedures for the Measurement of Catalytic Activity Concentrations of Enzymes at 37°C. Part 2. Reference Procedure for the Measurement of Catalytic Concentration of Creatine Kinase (2002) (148)
Use of Biochemical Markers in Acute Coronary Syndromes. IFCC Scientific Division, Committee on Standardization of Markers of Cardiac Damage (1999) (142)
Hyperuricemia as risk factor for coronary heart disease incidence and mortality in the general population: a systematic review and meta-analysis (2016) (128)
Standardization of cardiac troponin I assays: round Robin of ten candidate reference materials. (2001) (116)
Criteria for assigning laboratory measurands to models for analytical performance specifications defined in the 1st EFLM Strategic Conference (2017) (116)
Preanalytical quality improvement. In pursuit of harmony, on behalf of European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working group for Preanalytical Phase (WG-PRE) (2015) (112)
The exciting story of cardiac biomarkers: from retrospective detection to gold diagnostic standard for acute myocardial infarction and more. (2006) (111)
Soluble transferrin receptor (sTfR) and sTfR/log ferritin index for the diagnosis of iron-deficiency anemia. A meta-analysis. (2012) (103)
Single-point cardiac troponin T at coronary care unit discharge after myocardial infarction correlates with infarct size and ejection fraction. (2002) (102)
Cardiac troponin elevations in chronic renal failure: prevalence and clinical significance. (1999) (99)
Toward standardization of cardiac troponin I measurements part II: assessing commutability of candidate reference materials and harmonization of cardiac troponin I assays. (2006) (98)
Aspartate aminotransferase isoenzymes. (1990) (95)
Common reference intervals for aspartate aminotransferase (AST), alanine aminotransferase (ALT) and γ-glutamyl transferase (GGT) in serum: results from an IFCC multicenter study (2010) (93)
Measurement of pancreatic lipase activity in serum by a kinetic colorimetric assay using a new chromogenic substrate (2001) (93)
Traceability as a unique tool to improve standardization in laboratory medicine. (2009) (91)
Harmonization of automated hemolysis index assessment and use: Is it possible? (2014) (90)
Diagnostic and prognostic implications using age- and gender-specific cut-offs for high-sensitivity cardiac troponin T - Sub-analysis from the TRAPID-AMI study. (2016) (90)
The importance of metrological traceability on the validity of creatinine measurement as an index of renal function: International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) (2006) (89)
IFCC Primary Reference Procedures for the Measurement of Catalytic Activity Concentrations of Enzymes at 37C. Part 6. Reference Procedure for the Measurement of Catalytic Concentration of γ-Glutamyltransferase (2002) (87)
Enzymatic assays for creatinine: Time for action (2008) (86)
Cardiac troponin: a critical review of the case for point-of-care testing in the ED. (2012) (86)
National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biomarkers of heart failure. (2007) (85)
Standardization in laboratory medicine: new challenges. (2005) (84)
Acute coronary syndrome: biochemical strategies in the troponin era. (2002) (82)
Traceability, reference systems and result comparability. (2007) (82)
IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 °C. Part 9: Reference procedure for the measurement of catalytic concentration of alkaline phosphatase (2011) (81)
The analytical goals for hemoglobin A(1c) measurement in IFCC units and National Glycohemoglobin Standardization Program Units are different. (2011) (78)
The Sensitivity of Cardiac Markers: an Evidence-based Approach (1999) (77)
IFCC Working Group Recommendations for Assessing Commutability Part 1: General Experimental Design. (2018) (76)
Assay-related issues in the measurement of cardiac troponins. (2009) (75)
IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. International Federation of Clinical Chemistry and Laboratory Medicine. Part 6. Reference procedure for the measurement of catalytic concentration of gamma-glutamyltransferase. (2002) (74)
Standardisation of cardiac troponin I measurement: past and present (2010) (74)
Defining a roadmap for harmonizing quality indicators in Laboratory Medicine: a consensus statement on behalf of the IFCC Working Group “Laboratory Error and Patient Safety” and EFLM Task and Finish Group “Performance specifications for the extra-analytical phases” (2017) (70)
National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: Analytical issues for biomarkers of heart failure. (2008) (70)
IFCC Working Group Recommendations for Assessing Commutability Part 2: Using the Difference in Bias between a Reference Material and Clinical Samples. (2018) (70)
Impact of age on the performance of the ESC 0/1h-algorithms for early diagnosis of myocardial infarction (2018) (69)
Implementation of standardization in clinical practice: not always an easy task (2012) (69)
The Use of Very Low Concentrations of High-sensitivity Troponin T to Rule Out Acute Myocardial Infarction Using a Single Blood Test. (2016) (67)
Generation of data on within-subject biological variation in laboratory medicine: An update (2016) (66)
Verification of in vitro medical diagnostics (IVD) metrological traceability: responsibilities and strategies. (2014) (66)
Results from a multicenter evaluation of the 4th generation Elecsys Troponin T assay. (2007) (65)
Application of traceability concepts to analytical quality control may reconcile total error with uncertainty of measurement (2010) (64)
Enzymatic assays for creatinine: time for action. (2008) (63)
IFCC Primary Reference Procedures for the Measurement of Catalytic Activity Concentrations of Enzymes at 37°C. Part 3. Reference Procedure for the Measurement of Catalytic Concentration of Lactate Dehydrogenase (2002) (61)
Defining analytical performance specifications 15 years after the Stockholm conference (2015) (60)
The future of laboratory medicine: understanding the new pressures. (2004) (60)
IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes of 37°C (2002) (60)
The Asian project for collaborative derivation of reference intervals: (1) strategy and major results of standardized analytes (2013) (59)
Prognostic Utility of a Modified HEART Score in Chest Pain Patients in the Emergency Department (2017) (58)
Revaluation of biological variation of glycated hemoglobin (HbA(1c)) using an accurately designed protocol and an assay traceable to the IFCC reference system. (2011) (58)
Promoting clinical and laboratory interaction by harmonization. (2014) (58)
A comprehensive appraisal of laboratory biochemistry tests as major predictors of COVID-19 severity. (2020) (58)
Standardization of troponin I measurements: an update (2008) (57)
Establishing a Reference System in Clinical Enzymology (2001) (57)
Serum albumin: accuracy and clinical use. (2013) (56)
Trueness verification of actual creatinine assays in the European market demonstrates a disappointing variability that needs substantial improvement. An international study in the framework of the EC4 creatinine standardization working group (2008) (56)
International survey on the use of cardiac markers. (2001) (56)
Biological variability of glycated hemoglobin. (2010) (55)
Harmonization of laboratory testing - Current achievements and future strategies. (2014) (54)
[Recommendations for the clinical use of cardiac natriuretic peptides]. (2005) (53)
Focusing on the clinical impact of standardization of creatinine measurements: a report by the EFCC Working Group on Creatinine Standardization (2011) (53)
Performance criteria for combined uncertainty budget in the implementation of metrological traceability (2015) (52)
Human epididymis protein 4: factors of variation. (2015) (52)
Biological variation in bone-derived biochemical markers in serum. (1995) (50)
Determination of aspartate aminotransferase isoenzymes in hepatic diseases--preliminary findings. (1983) (49)
Biological variation of neuroendocrine tumor markers chromogranin A and neuron-specific enolase. (2013) (49)
Standardization of cardiac troponin I measurements: the way forward? (2005) (48)
Total laboratory automation: Do stat tests still matter? (2017) (48)
Revaluating serum ferritin as a marker of body iron stores in the traceability era (2012) (47)
Proposals from IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD): recommendations on use of biochemical markers of cardiac damage in acute coronary syndromes. (1999) (47)
Laboratory medicine in the new healthcare environment (2016) (46)
Soluble transferrin receptor in complicated anemia. (2014) (45)
Proposals from the IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD): strategies and concepts on standardization of cardiac marker assays. (1999) (44)
Prevalence of Pancreatic Insufficiency in Inflammatory Bowel Diseases. Assessment by Fecal Elastase-1 (2007) (44)
Analytical performance specifications for external quality assessment – definitions and descriptions (2017) (44)
Strategies to define performance specifications in laboratory medicine: 3 years on from the Milan Strategic Conference (2017) (43)
The new definition of myocardial infarction and the impact of troponin determination on clinical practice. (2006) (43)
Diagnostic value of transferrin. (2012) (42)
How to assess the quality of your analytical method? (2015) (40)
Performance of today's cardiac troponin assays and tomorrow's. (2002) (40)
The utility of measurement uncertainty in medical laboratories (2020) (40)
Clinical and analytical evaluation of a continuous enzymatic method for measuring pancreatic lipase activity. (1993) (39)
IFCC Working Group Recommendations for Assessing Commutability Part 3: Using the Calibration Effectiveness of a Reference Material. (2018) (38)
Cardiac troponin T in serum as marker for myocardial injury in newborns. (1997) (38)
Present issues in the determination of troponins and other markers of cardiac damage. (2000) (38)
Defining acceptable limits for the metrological traceability of specific measurands (2013) (37)
Understanding the clinical biochemistry of N-terminal pro-B-type natriuretic peptide: the prerequisite for its optimal clinical use. (2004) (37)
Implementation of haemoglobin A1c results traceable to the IFCC reference system: the way forward (2007) (37)
Obtaining reference intervals traceable to reference measurement systems: is it possible, who is responsible, what is the strategy? (2012) (37)
Trueness verification and traceability assessment of results from commercial systems for measurement of six enzyme activities in serum: an international study in the EC4 framework of the Calibration 2000 project. (2006) (36)
Isoforms of creatine kinase MM and MB in acute myocardial infarction: a clinical evaluation. (1986) (36)
Progress and impact of enzyme measurement standardization (2017) (36)
Biological variation of myoglobin in serum. (1997) (36)
The measurement of cardiac markers: where should we focus? (2002) (36)
Evaluation of the impact of standardization process on the quality of serum creatinine determination in Italian laboratories. (2014) (35)
Diagnostic application of CK-MB mass determination. (1998) (35)
Biological Variation in Urinary Excretion of Pyridinium Crosslinks: Recommendations for the Optimum Specimen (1996) (35)
Serial Sampling of High-Sensitivity Cardiac Troponin T May Not Be Required for Prediction of Acute Myocardial Infarction Diagnosis in Chest Pain Patients with Highly Abnormal Concentrations at Presentation. (2017) (35)
The role of laboratory in ensuring appropriate test requests. (2017) (35)
Serum isoforms of creatine kinase isoenzymes. (1988) (35)
Procalcitonin: Between evidence and critical issues. (2019) (34)
Standardization in clinical enzymology: a challenge for the theory of metrological traceability (2010) (34)
Standardization and analytical goals for glycated hemoglobin measurement (2013) (34)
Biologic variability of C-reactive protein: is the available information reliable? (2012) (32)
Evaluation of a sandwich enzyme-linked immunosorbent assay for the measurement of serum heart fatty acid-binding protein (2002) (32)
Role and Responsibilities of Laboratory Medicine Specialists in the Verification OF Metrological Traceability of in vitro Medical Diagnostics (2015) (31)
Diagnostic value of measuring pancreatic lipase and the P3 isoform of the pancreatic amylase isoenzyme in serum of hospitalized hyperamylasemic patients. (1989) (30)
Clinical and Diagnostic Significance of Aspartate Aminotransferase Isoenzymes in Sera of Patients with Liver Diseases (1984) (30)
A critical appraisal of experimental factors influencing the definition of the 99th percentile limit for cardiac troponins (2009) (29)
Pre-analytical and biological variability of prostatic acid phosphatase and prostate-specific antigen in serum from patients with prostatic pathology. (1992) (29)
Once upon a time: a tale of ISO 15189 accreditation (2015) (29)
A new robust statistical model for interpretation of differences in serial test results from an individual (2015) (29)
Rapid Determination of Brain Natriuretic Peptide in Patients with Acute Myocardial Infarction (2003) (28)
Commutability of reference and control materials: an essential factor for assuring the quality of measurements in Laboratory Medicine (2019) (28)
Isoforms of creatine kinase isoenzymes in serum in acute myocardial infarction after intracoronary thrombolysis. (1987) (28)
Comparison of the diagnostic performance of two rapid bedside biochemical assays in the early detection of acute myocardial infarction (1998) (27)
Activity of serum aspartate aminotransferase isoenzymes in patients with acute myocardial infarction. (1987) (27)
Pre-analytical and analytical aspects affecting clinical reliability of plasma glucose results. (2017) (27)
The internal quality control in the traceability era (2020) (26)
Evaluation of standardization capability of current cardiac troponin I assays by a correlation study: results of an IFCC pilot project (2015) (26)
Selection of antibodies and epitopes for cardiac troponin immunoassays: should we revise our evidence-based beliefs? (2005) (26)
The new definition of myocardial infarction: analysis of the ESC/ACC Consensus Document and reflections on its applicability to the Italian Health System. (2002) (26)
The importance of individual biology in the clinical use of serum biomarkers for ovarian cancer (2014) (25)
5'-Nucleotidase in the detection of increased activity of the liver form of alkaline phosphatase in serum. (2001) (25)
Benign inherited hyperphosphatasemia of intestinal origin: report of two cases and a brief review of the literature. (1991) (24)
Rapid, highly sensitive immunoassay for determination of cardiac troponin I in patients with myocardial cell damage. (1997) (24)
Colour coding for blood collection tube closures – a call for harmonisation (2015) (24)
Standardization activities of markers of cardiac damage: the need of a comprehensive approach. (1998) (23)
Performance specifications for measurement uncertainty of common biochemical measurands according to Milan models (2021) (23)
Making new biomarkers a reality: the case of serum human epididymis protein 4 (2018) (23)
Total error vs. measurement uncertainty: the match continues (2016) (23)
IFCC Committee on Standardization of Markers of Cardiac Damage: Premises and Project Presentation (1998) (22)
The role of external quality assessment in the verification of in vitro medical diagnostics in the traceability era. (2018) (22)
Characterization of a rapid immunochromatographic assay for simultaneous detection of high concentrations of myoglobin and CK-MB in whole blood. (1996) (22)
Definition of Outcome-Based Prostate-Specific Antigen (PSA) Thresholds for Advanced Prostate Cancer Risk Prediction (2021) (22)
Combined testing of copeptin and high-sensitivity cardiac troponin T at presentation in comparison to other algorithms for rapid rule-out of acute myocardial infarction. (2019) (22)
Evaluation of a Fully Automated Assay to Measure C-Telopeptide of Type I Collagen in Serum (2000) (21)
Traceability in clinical enzymology. (2007) (21)
Searching for a role of procalcitonin determination in COVID-19: a study on a selected cohort of hospitalized patients (2020) (21)
Serum α-fetoprotein in pediatric oncology: not a children’s tale (2018) (21)
Is the accuracy of serum albumin measurements suitable for clinical application of the test? (2011) (21)
Serum Prostate-Specific Antigen Testing for Early Detection of Prostate Cancer: Managing the Gap between Clinical and Laboratory Practice. (2021) (21)
Verification of the harmonization of human epididymis protein 4 assays (2016) (21)
Evaluation of the trueness of serum alkaline phosphatase measurement in a group of Italian laboratories (2017) (20)
Frequency of butyrylcholinesterase gene mutations in individuals with abnormal inhibition numbers: an Italian-population study. (2003) (20)
Recent approaches in standardization of cardiac markers. (2001) (20)
Human Chorionic Gonadotropin Assays for Testicular Tumors: Closing the Gap between Clinical and Laboratory Practice. (2018) (20)
10% CV concentration for the fourth generation Roche cardiac troponin T assay derived from Internal Quality Control data (2006) (20)
Serum concentrations of lipoprotein(a) during normal pregnancy and postpartum. (1991) (20)
Enzyme and muscle diseases (1995) (20)
Verification of Harmonization of Serum Total and Free Prostate-Specific Antigen (PSA) Measurements and Implications for Medical Decisions. (2020) (19)
Laboratory testing in the emergency department: an Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC) and Academy of Emergency Medicine and Care (AcEMC) consensus report (2017) (19)
Defining permissible limits for the combined uncertainty budget in the implementation of metrological traceability. (2018) (19)
Current concepts in standardization of cardiac marker immunoassays (2004) (19)
Measurement uncertainty: Friend or foe? (2018) (19)
Pre-Analytical, Analytical and Biological Sources of Variation of Lipoprotein(a) (1993) (19)
Hypoalbuminemia and elevated D-dimer in COVID-19 patients: a call for result harmonization (2020) (19)
Comparative study of a new quantitative rapid test with an established ELISA method for faecal calprotectin. (2012) (18)
Serum and plasma samples for ACS:systems cardiac markers. (2000) (18)
Multicenter evaluation of five assays for myoglobin determination. (2000) (18)
Implementation of metrological traceability in laboratory medicine: where we are and what is missing (2020) (18)
Multicenter evaluation of analytical performance of the Liaison troponin I assay. (2004) (18)
Tackling serum folate test in European countries within the health technology assessment paradigm: request appropriateness, assays and health outcomes (2017) (18)
Determination of Decision Limits for ACS:Systems Cardiac Troponin I (2000) (18)
Measurement of troponin I 48h after admission as a tool to rule out impaired left ventricular function in patients with a first myocardial infarction (2005) (18)
Biological variation of lactate and pyruvate in blood. (1993) (17)
Plasma midregional proadrenomedullin (MR-proADM) concentrations and their biological determinants in a reference population (2018) (17)
Standardization of immunoassays for measurement of myoglobin in serum. Phase I: evaluation of candidate secondary reference materials. (2004) (17)
Time course of changes in pancreatic enzymes, isoenzymes and, isoforms in serum after endoscopic retrograde cholangiopancreatography. (1991) (17)
Inside ST-elevation myocardial infarction by monitoring concentrations of cardiovascular risk biomarkers in blood. (2012) (17)
Recommendations on Use of Biochemical Markers in Acute Coronary Syndrome: IFCC Proposals (2003) (17)
Rapid and specific immunoassay for cardiac troponin I in the diagnosis of myocardial damage (1997) (17)
Is serum human epididymis protein 4 ready for prime time? (2014) (17)
American Liver Guidelines and Cutoffs for "Normal" ALT: A Potential for Overdiagnosis. (2017) (17)
Gaps in the traceability chain of human growth hormone measurements. (2013) (17)
Principles of clinical enzymology (2008) (17)
Diagnostic value of a single measurement of troponin T in serum for suspected acute myocardial infarction. (1994) (17)
Recommendations for the Routine Use of Pancreatic Amylase Measurement instead of Total Amylase for the Diagnosis and Monitoring of Pancreatic Pathology (2002) (17)
Measurement of Serum Neuron-Specific Enolase in Neuroblastoma: Is There a Clinical Role? (2020) (17)
Standardization of ceruloplasmin measurements is still an issue despite the availability of a common reference material (2010) (17)
The calibrator value assignment protocol of the Abbott enzymatic creatinine assay is inadequate for ensuring suitable quality of serum measurements. (2015) (16)
Development of a candidate secondary reference procedure (immunoassay based measurement procedure of higher metrological order) for cardiac troponin I: I. Antibody characterization and preliminary validation (2010) (16)
Lactate dehydrogenase: an old enzyme reborn as a COVID-19 marker (and not only) (2020) (15)
Multiple Micronutrients and Docosahexaenoic Acid Supplementation during Pregnancy: A Randomized Controlled Study (2020) (15)
IFCC Working Group Recommendations for Correction of Bias Caused by Noncommutability of a Certified Reference Material Used in the Calibration Hierarchy of an End-User Measurement Procedure. (2020) (15)
Quality requirements for troponin assays – An overview (2012) (15)
Random uncertainty of photometric determination of hemolysis index on the Abbott Architect c16000 platform. (2018) (15)
The Analytical Goals for Hemoglobin A1c Measurement in IFCC Units and National Glycohemoglobin Standardization (2011) (15)
Recent approaches to the standardization of cardiac markers (2001) (14)
Establishing reference intervals for galectin-3 concentrations in serum requires careful consideration of its biological determinants. (2017) (14)
Comparative study of cardiac troponin I and T measurements in a routine extra‐cardiological clinical setting (2001) (14)
Serum enzymes in acute myocardial infarction after intracoronary thrombolysis. (1986) (14)
Standardisation--the theory and the practice. (2007) (14)
Laboratory medicine as the science that underpins medicine: the “high-sensitivity” troponin paradigm (2015) (14)
Nonenzymic glycation of apolipoprotein B in patients with insulin- and noninsulin-dependent diabetes mellitus. (1995) (14)
"Harmonization of laboratory testing - A global activity". (2014) (14)
Multicentre evaluation of a high sensitive Elecsys troponin T assay (2009) (13)
Electrophoretic fractionation of pancreatic lipase. (1992) (13)
Determination of Glycated Apolipoprotein B in Serum by a Combination of Affinity Chromatography and Immunonephelometry (1994) (13)
Clinical evaluation of an algorithm for the interpretation of hyperamylasemia. (1991) (13)
Tumor Marker Ordering: Do Not Lose Control: A Prospective Clinical Trial. (2015) (13)
IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. International Federation of Clinical Chemistry and Laboratory Medicine. Part 7. Certification of four reference materials for the determination of enzymatic activity of gamma-glutam (2002) (13)
Standardization and analytical goals for glycated hemoglobin measurement (2013) (13)
Fast track protocols using highly sensitive troponin assays for ruling out and ruling in non-ST elevation acute coronary syndrome (2017) (13)
Serum human epididymis protein 4 vs. carbohydrate antigen 125 in ovarian cancer follow-up. (2018) (12)
Coronary angiographic findings in patients with clinical unstable angina according to cardiac troponin I and T concentrations in serum. (2002) (12)
Biochemical assessment of myocardial damage with new diagnostic tools. (1999) (12)
An approach for determining allowable between reagent lot variation (2022) (12)
Traceability validation of six enzyme measurements on the Abbott Alinity c analytical system (2020) (12)
AACC creatine kinase MB (CK-MB) standardization material used as manufacturer's working calibrator is unable to harmonize CK-MB results between two commercial immunoassays. (2004) (12)
Biologic variation of copper, ceruloplasmin and copper/ceruloplasmin ratio (Cu:Cp) in serum. (2013) (12)
How Clinical Laboratories May Improve Their Performance: The "High-Sensitivity" Troponin Paradigm. (2018) (12)
High sensitivity cardiac troponin T in patients not having an acute coronary syndrome: results from the TRAPID-AMI study (2017) (12)
Biological variation in serum activities of three hepatic enzymes. (2001) (12)
Multicenter evaluation of the TOSOH AIA-pack second-generation cardiac troponin I assay. (2004) (11)
Heparinate but not serum tubes are susceptible to hemolysis by pneumatic tube transportation (2016) (11)
Effect of long term simvastatin administration as an adjunct to ursodeoxycholic acid: evidence for a synergistic effect on biliary bile acid composition but not on serum lipids in humans (1999) (11)
Analytical validation of a highly sensitive point-of-care system for cardiac troponin I determination (2019) (11)
Innotrac aio! Second-generation cardiac troponin I assay: imprecision profile and other key characteristics for clinical use. (2004) (11)
Body mass index does not influence human epididymis protein 4 concentrations in serum. (2015) (11)
Measurement of cardiac troponins revisited (2008) (11)
Biological variation of free light chains in serum. (2013) (11)
Evaluation of a development version of the elecsys high sensitive troponin T assay (2008) (11)
Cardiac Natriuretic Hormones as Markers of Cardiovascular Disease: Methodological Aspects (2006) (11)
The importance of analytical quality specifications for biomarker assays currently used in acute cardiac care (2006) (11)
Reference Interval for Lactate Dehydrogenase Catalytic Activity in Serum Measured According to the New IFCC Recommendations (2003) (11)
Serum isoforms of creatine kinase MM and MB in myocardial infarction. An appraisal of quantitative, clinical and pathophysiological information. (1987) (11)
Serum folate concentrations in patients with cortical and subcortical dementias (2007) (11)
Diagnostic value of four assays for lipase determination in serum: a comparative reevaluation. (1991) (11)
Biochemical markers of cardiac diseases (2004) (11)
A study of biological and lifestyle factors, including within-subject variation, affecting concentrations of growth differentiation factor 15 in serum (2018) (11)
Derivation of performance specifications for uncertainty of serum C-reactive protein measurement according to the Milan model 3 (state of the art) (2020) (11)
Impact of implementation of the high-sensitivity cardiac troponin T assay in a university hospital setting. (2011) (11)
Better blood collection tubes for plasma glucose: ready for prime time? (2014) (11)
Evaluation of a new method for cholinesterase determination. (1986) (11)
Measurement of icteric index as approach to detect abnormal total bilirubin values (2013) (10)
Laboratory-related issues in the measurement of cardiac troponins with highly sensitive assays (2020) (10)
A Summary of Worldwide National Activities in Chronic Kidney Disease (CKD) Testing (2017) (10)
Significance of various parameters derived from biological variability for lipid and lipoprotein analyses. (1993) (10)
Automated immunoassay of cardiac Troponin I in serum evaluated. (1997) (10)
New insights in the pathophysiology of acute myocardial infarction detectable by a contemporary troponin assay. (2013) (10)
Hemoglobin, bilirubin, and lipid interference on Roche Cobas 6000 assays. (2012) (10)
Documenting metrological traceability as intended by ISO 15189:2012: A consensus statement about the practice of the implementation and auditing of this norm element (2018) (10)
Implementation of standardization of HbA1c measurement (2008) (10)
Cardiac Myosin Light Chains (1992) (10)
Estimating Glomerular Filtration Rate from Serum Creatinine Measurements: Analytical Issues and Standardization Programs (2007) (9)
Estimation of the reference interval for serum folate measured with assays traceable to the WHO International Standard (2017) (9)
Estimate of intraindividual variability of C-reactive protein: a challenging issue. (2013) (9)
Optimal collection tubes for plasma glucose determination: confusion reigns supreme (2016) (9)
Imprecision of tumour biomarker measurements on Roche Modular E170 platform fulfills desirable goals derived from biological variation (2010) (9)
Symptoms Predictive of Acute Myocardial Infarction in the Troponin Era: Analysis From the TRAPID-AMI Study (2016) (9)
Evaluation of a New Continuous Colorimetric Method for Determination of Serum Pseudocholinesterase Catalytic Activity and its Application to a Centrifugal Fast Analyser (1984) (9)
Trueness evaluation and verification of inter-assay agreement of serum folate measuring systems (2020) (9)
Diagnostic value of measuring pancreatic isoamylase with a double–monoclonal antibody immunoassay in serum of hospitalized hyperamylasemic patients (1990) (9)
Diurnal rhythm in urinary excretion of pyridinium crosslinks. (1994) (9)
The never-ending search of an acceptable compromise for pancreatic lipase standardisation (2012) (9)
Commutability of the ERM-DA470k Reference Material for two assays measuring serum albumin using immunochemical principles (2011) (9)
Fatal electrolyte abnormalities following enema administration. (2012) (9)
Comparison of catalytic activity and mass concentration of serum creatine kinase MB isoenzyme in the detection of coronary reperfusion in acute myocardial infarction after therapeutic thrombolysis. (1988) (8)
Cardiac: Is this biomarker ready for the prime time? (2010) (8)
Tracing a roadmap for vitamin B12 testing using the health technology assessment approach (2014) (8)
International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) 3) (2008) (8)
More on the accuracy of the Architect enzymatic assay for hemoglobin A1c and its traceability to the IFCC reference system (2016) (8)
Evaluation of long-term imprecision of automated complete blood cell count on the Sysmex XN-9000 system (2017) (8)
Reference intervals for two bone-derived enzyme activities in serum: bone isoenzyme of alkaline phosphatase (ALP) and tartrate-resistant acid phosphatase (TR-ACP). (1989) (8)
The changing face of laboratory medicine: a more service and less academically oriented profession? (2015) (8)
An immunochemical procedure for determination of creatine kinase 3(1) (serum-specific) isoform in human serum evaluated. (1990) (8)
Sources and clinical significance of aspartate aminotransferase increases in COVID-19 (2021) (7)
Pre-analytical factors affecting troponin measurement (2012) (7)
Serum potassium concentrations in COVID-19 (2020) (7)
Traceability of values for catalytic activity concentration of enzymes: a Certified Reference Material for aspartate transaminase (2010) (7)
Electrophoretic fractionation of 5'-nucleotidase. (1994) (7)
Evaluation of the direct potentiometric method for serum chloride determination--comparison with the most commonly employed methodologies. (1986) (7)
Assay Using Succinyldithiocholine as Substrate: The Method of Choice for the Measurement of Cholinesterase Catalytic Activity in Serum to Diagnose Succinyldicholine Sensitivity (2003) (7)
Evaluation of a Rapid Bedside Immunochromatographic Assay for Detection of Cardiac Troponin I in Whole Blood (2001) (7)
External Quality Assessment for biochemical markers of myocardial damage: an Italian experience (2004) (7)
[Biochemical markers for predicting chemotherapy-induced cardiotoxicity: systematic review of the literature and recommendations for use]. (2006) (7)
Optimizing Available Tools for Achieving Result Standardization: Value Added by Joint Committee on Traceability in Laboratory Medicine (JCTLM). (2021) (6)
What's in a name? Standardisation of HbA1c: a response (2008) (6)
Prognostic role of Krebs von den Lungen-6 (KL-6) measurement in idiopathic pulmonary fibrosis: a systematic review and meta-analysis (2021) (6)
Trueness Evaluation and Verification of Interassay Agreement of 11 Serum IgA Measuring Systems: Implications for Medical Decisions. (2019) (6)
Clinical Governance Remains a Priority in Total Laboratory Automation Era. (2019) (6)
Daily monitoring of a control material with a concentration near the limit of detection improves the measurement accuracy of highly sensitive troponin assays (2019) (6)
Target organ damage in a population at intermediate cardiovascular risk, with adjunctive major risk factors: CArdiovascular PREvention Sacco Study (CAPRESS) (2011) (6)
A step forward in identifying the right human chorionic gonadotropin assay for testicular cancer (2019) (6)
Time course of changes in serum activity of the P3 isoform of pancreatic amylase isoenzyme in patients with acute pancreatitis. (1989) (6)
Clinical and analytical performance of automated immunochemiluminometric assays for determination of cardiac markers in serum. (1998) (6)
Cystatin C provides a better estimate of the effect of glomerular filtration rate on serum human epididymis protein 4 concentrations (2016) (6)
Improving measurement uncertainty of plasma electrolytes: a complex but not impossible task (2020) (6)
Implementation of new recommendations for the diagnosis of gestational diabetes: a 5-month audit (2011) (5)
Standardization of Cardiac Markers (2003) (5)
The interfering component in cardiac troponin I immunoassays: need for further experimental evidence. (2004) (5)
Frequency of Pancreatic Hyperamylasemia in Human Immunodeficiency Virus-Positive Patients in the Highly Active Antiretroviral Therapy Era. (2016) (5)
Certification of the Mass Concentration of Creatine Kinase Isoenzyme 2 (CK-MB) in the Reference Material BCR 608 (2001) (5)
Lipase elevation in serum of COVID-19 patients: frequency, extent of increase and clinical value (2021) (5)
Harmonization Status of Serum Ferritin Measurements and Implications for Use as Marker of Iron-Related Disorders. (2022) (5)
CK-MM interference with an immunoenzymometric method for quantification of CK-MB in serum. (1989) (5)
The simple reproducibility of a measurement result does not equal its overall measurement uncertainty (2022) (5)
Glycolysis inhibition and reliable plasma glucose results: is the clinical impact carefully considered? (2015) (5)
A simple method for quantitative determination of lipoprotein-X (LP-X) in human serum. (1985) (5)
Traceability of alkaline phosphatase measurement may also vary considerably using the same analytical system: the case of Abbott Architect (2017) (5)
On the comparison of serum and plasma samples in troponin assays. (2003) (5)
SARS-CoV-2 serologic tests: do not forget the good laboratory practice (2020) (4)
Folate and vitamin B12 assays after recalibration to the WHO International Standard 03/178: making the interpretation as simple as possible, but not simpler (2019) (4)
Defining the plasma folate concentration for optimal neural tube defects prevention cannot ignore the impact of the employed methodology. (2019) (4)
Effects of therapeutic coronary reperfusion on aspartate aminotransferase isoenzymes in sera of patients with acute myocardial infarction. (1989) (4)
Evaluation of the sensitivity of two highly sensitive troponin assays for early detection of non ST - elevation myocardial infarction (NSTEMI) (2011) (4)
A continuous enzymatic UV method for determination of pancreatic lipase activity in serum evaluated (1990) (4)
Recommendation to harmonize the units for reporting cardiac troponin results. (2014) (4)
Commutability of two JCTLM-listed secondary reference materials for two commercial lithium assays. (2012) (4)
Redefining reference limits needs more attention to the analytical aspects (2006) (4)
Interpreting EQA-Understanding Why Commutability of Materials Matters. (2022) (4)
Definition of analytical quality specifications for serum total folate measurements using a simulation outcome-based model (2019) (4)
Letter to the Editor: Serum Albumin in COVID‐19: A Good Example in Which Analytical and Clinical Performance of a Laboratory Test Are Strictly Intertwined (2021) (4)
Triglyceride interference with an immunoturbidimetric quantification of lipoprotein(a) in serum. (1994) (4)
Implementation of an internal quality control programme for the photometric determination of icteric index (2018) (4)
Impact of optimizing pre-analytical phase on the diagnosis of gestational diabetes and related outcomes (2021) (4)
Definition and application of performance specifications for measurement uncertainty of 23 common laboratory tests: linking theory to daily practice (2022) (4)
Avoid capture of interfering molecules in cardiac troponin immunoassays: working in shifts. (2013) (4)
Clinical impact of glycolysis inhibition on plasma glucose results requires caution (2017) (4)
[Markers of myocardial damage in the diagnosis of acute myocardial infarction: the Italian reality in the year 2000]. (2002) (4)
Novel generations of laboratory instruments should not worsen analytical quality: The case of GEM Premier 5000. (2018) (3)
Relation of age to isoenzyme patterns of amylase in serum (1984) (3)
Pancreatic lipase: why laboratory community does not take enough care of this clinically important test? (2021) (3)
Use of Serum on Guthrie Cards in Screening for Congenital Disorders of Glycosylation (2006) (3)
Enzyme and rate analyses (2015) (3)
An enzymatic method for lactate in whole blood adapted to the Cobas Bio. (1989) (3)
Reply to Westgard et al.: ‘Keep your eyes wide … as the present now will later be past’* (2022) (3)
Multicentre Evaluation of the Second Generation Elecsys NT-proBNP Assay (2008) (3)
Human chorionic gonadotropin in oncology: a matter of tight (bio)marking (2019) (3)
[Cardiac troponin I and T in unstable angina: incidence, correlation, kinetics of release and prognostic value]. (1996) (3)
Hyperuricemia (HUA) as an independent risk factor for coronary heart disease (CHD) in the general population: a systematic review and meta-analysis (2015) (3)
[New definition of myocardial infarction: analysis of the consensus document ESC/ACC and thoughts about applicability to the Italian health situation]. (2002) (3)
Validation of the reticulocyte channel of Sysmex XN-9000 system for blood cell count in samples with suspected cold agglutination for use in a total laboratory automation setting (2020) (3)
Impact of total automation consolidating first-line laboratory tests on diagnostic blood loss (2019) (3)
The prognostic value of plasma fibrinogen concentrations of patients with ST-elevation myocardial infarction and treated by primary percutaneous coronary intervention: A cautionary message (2012) (3)
IFCC Scientific Division (2010) (3)
Methods for serum cholinesterase assay and classification of genetic variants. (1989) (3)
Redesigning the surveillance of in vitro diagnostic medical devices and of medical laboratory performance by quality control in the traceability era (2022) (3)
Offering Aspartate Aminotransferase as a Reflex Test: An Easy but Effective Way to Improve Appropriateness of Laboratory Requests. (2018) (3)
Reference intervals for the Kryptor second-generation chromogranin A assay (2016) (3)
Are blood ammonia concentrations dependent on γ-glutamyl-transferase levels in plasma? (2016) (3)
Pyruvate measured in whole blood with the Cobas Bio analyzer. (1989) (3)
Hepatic alkaline phosphatase isoenzyme. II : Clinical aspects (1990) (3)
Pursuing appropriateness of laboratory tests: a 15-year experience in an academic medical institution (2022) (3)
Is pre-biopsy serum prostate specific antigen retesting always justified? A study of the influence of individual and analytical factors on decision making for biopsy referral. (2021) (3)
Differences between Educational and Regulatory External Quality Assurance/Proficiency Testing Schemes. (2022) (2)
An Immunoinhibition Assay for Determination of Creatine Kinase Isoforms in Serum (1994) (2)
An Alternative Approach to the Prevention of Succinyldicholine-Induced Apnoea (1988) (2)
Sensitivity of bone remodeling markers in elderly male patients chronically treated with glucocorticoids. (1999) (2)
Verifica dell’accuratezza di tre glucometri “point-of-care” per l’utilizzo in ambito ospedaliero = Verification of accuracy of 3 glucose point-of-care testing (POCT) devices for their use in a hospital setting (2017) (2)
Recommendations for assessing commutability part 3: based on the calibration effectiveness of a reference material (2018) (2)
Impact of the implementation of higlhy sensitivie cardiac troponin T assay in a università hospital setting (2011) (2)
Alignment of the new generation of Abbott Alinity γ-glutamyltransferase assay to the IFCC reference measurement system should be improved (2022) (2)
Linking lactate dehydrogenase to the severity of COVID-19 cannot ignore the employed methodology (2020) (2)
Evaluation of a new commercial assay kit for quantification of lactate dehydrogenase isoenzyme 1 in serum. (1990) (2)
Improving D-dimer testing appropriateness by controlling periodicity of retesting: prevention is better than cure (2022) (2)
Aspartate aminotransferase in COVID‐19: A probably overrated marker (2021) (2)
More robust analytical evidence should support the selection of human chorionic gonadotropin assays for oncology application (2019) (2)
A step towards optimal efficiency of HbA1c measurement as a first-line laboratory test: the TOP-HOLE (Towards OPtimal glycoHemOgLobin tEsting) project (2022) (2)
Multi-marker network in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: when and what to measure. (2013) (2)
Myosin Light and Heavy Chains (1998) (2)
Verification of the accuracy of three glucose point-of-care testing (POCT) devices for their use in a hospital setting (2016) (2)
Prospective validation of an automatic reflex test for identifying spurious elevations of mean corpuscular haemoglobin concentration due to the presence of cold agglutinins (2021) (2)
[Biochemical markers of myocardial damage in acute coronary syndromes. Suggestions for their optimal use in clinical practice]. (1999) (2)
Labor Increases Maternal DNA Contamination in Cord Blood (2)
Chemiluminescence immunoassay of creatine kinase MB with an monoclonal antibody to the MB isoenzyme evaluated (1991) (2)
Suppressing all test results in grossly hemolyzed samples: is this approach appropriate in every case? (2018) (2)
Evaluation of a Commercial Immunoenzymometric Assay Kit for Creatine Kinase MB Isoenzyme Determination Using Monoclonal Antibodies (1986) (2)
National survey on the use of measurement of cholinesterase activity in serum (2005) (2)
Improving the Laboratory Result Release Process in the Light of ISO 15189:2012 Standard. (2021) (2)
Definition of the Immune Parameters Related to COVID-19 Severity (2022) (2)
Biochemical markers of cardiac damage : what is current , what is redundant ? * (2002) (2)
Different calibrator options may strongly influence the trueness of serum transferrin measured by Abbott Architect systems. (2018) (2)
Managing post-analytical phase of procalcitonin testing in intensive care unit improves the request appropriateness (2019) (2)
Diagnostic value of prostatic acid phosphatase and prostate-specific antigen in patients with prostatic cancer. (1990) (2)
Chloride binding to serum proteins. (1987) (2)
Cardiac marker testing following surgery. (2001) (2)
Use of Neurosoft expert system improves turnaround time in a laboratory section specialized in protein diagnostics: a two-year experience (2021) (2)
A monoclonal-antibody-based enzyme-linked immunosorbent assay for determination of lipoprotein(a) in serum evaluated (1991) (2)
Method for prostatic acid phosphatase (PAP) with sodium thymolphthalein monophosphate (STMP) as substrate, as adapted to the Cobas Bio. (1986) (1)
Pretreatment of serum with penicillamine: effects on capillary electrophoresis patterns and on immunonephelometric measurement of immunoglobulins. (2006) (1)
N-terminal proB-type natriuretic peptide testing: practical diagnostic value in a emergency department (2013) (1)
Biological variation in serum type I collagen carboxy-terminal telopeptide concentrations. (2000) (1)
Automated measurement of mitochondrial aspartate aminotransferase by selective proteolysis with proteinase K. (1993) (1)
‘Penelope test’: a practical instrument for checking appropriateness of laboratory tests (2022) (1)
The basics of cardiac biomarker interpretation * (1)
Improving clinical laboratory performance through quality indicators. (2017) (1)
Measurement imprecision of common urinary biochemical analytes on the Roche Cobas 6000 system (2013) (1)
Reply to "Analytical performance assessment of a novel cartridge-based blood gas analyzer". (2019) (1)
CK-MB isoform determination and early diagnosis of myocardial infarction. (1990) (1)
Biological variation of two serum markers for preeclampsia prediction (2019) (1)
Early Detection of the Selectivity Loss of the Cobas Integra Analyzer Chloride Ion-selective Electrode (1)
Biochemical markers in clinical cardiology: perspectives from present to future. 1st IFCC-Ortho Clinical Diagnostics Conference on Clinical Diagnosis and the Clinical Laboratory (2008) (1)
Biological variation of serum cholinesterase catalytic concentrations (2022) (1)
Troponin I: Structure, Physiology and It’s Role in Risk Stratification of Angina Patients (1998) (1)
Daily monitoring of a control material with a concentration between LOB and LOD improves the accuracy of highly sensitive troponin assay (2019) (1)
A single reagent method for determination of total and conjugated bilirubin with a centrifugal analyser. (1983) (1)
Impact of the highly sensitive cardiac troponin t (hsTnT) assay on the triage of emergency department (ED) patients (2011) (1)
Incidence and status of insulin secretion in pregnant women with flat plasma glucose profiles during oral glucose tolerance test. (2022) (1)
γ‐Glutamyltransferase reference intervals in detail (2022) (1)
Catalytic Concentration of gamma-Glutamyltransferase (GGT) Determined by IFCC Method at 37°C IRMM/IFCC-452. (2000) (1)
Standardisation--the theory and the practice. (2007) (1)
Defining the need for a dynamic multimarker approach (2013) (1)
A two-tube immunochemical method for determination of CK-MB isoenzyme in serum evaluated. (1990) (1)
Letter to the Editor: Establishing Reliable Pediatric Percentiles of Serum Liver Enzyme Concentrations Cannot Ignore the Employed Methodology (2019) (1)
Clinical Governance Should Be a Priority When Care Delivery Systems Are Disrupted. (2019) (1)
Revaluation of biological variation of HbA1c using an accurately designed protocol (2011) (1)
Erratum to "Establishing reference intervals for galectin-3 concentrations in serum requires careful consideration of its biological determinants" [Clin. Biochem. 50 (2017) 599-604]. (2017) (1)
Laboratory tests in the Emergency Department: a consensus document by SIBioC-Medicina di Laboratorio and the Academy of Emergency Medicine and Care. (2017) (1)
Further improvement of the quality of tube transportation system is needed to prevent 'seasonal' pseudohyperkalaemia. (2020) (1)
Improving the clinical value of laboratory information and permitting a common global approach to diseases. Foreword. (2010) (1)
Automatic reflex addition of serum magnesium determination to samples with severe hypocalcemia is an effective tool to detect and treat hypomagnesemia. (2021) (1)
Recent Advances in the Measurement of LDL Cholesterol in Serum. Neue Fortschritte bei der Messung von LDL Cholesterin in Serum (2001) (1)
Current performance of C-reactive protein determination and derivation of quality specifications for its measurement uncertainty (2023) (1)
Highly sensitive troponin T measurement after pneumatic tube transportation: the sample type can make the difference. (2020) (1)
Reply to: Hyperuricemia does not seem to be an independent risk factor for coronary heart disease (2017) (1)
Single-Point Troponin T Measurement On The Day Of Coronary Care Unit Discharge After Myocardial Infarction Strongly Correlates With Ejection Fraction And Infarct Size By Nuclear Imaging And With CK-MB Release (2004) (1)
More about the random uncertainty of photometric determination of hemolysis index on the Abbott Alinity c platform. (2022) (1)
Valutazione dell’esattezza della misura della fosfatasi alcalina sierica in un gruppo di laboratori italiani = Evaluation of the trueness of serum alkaline phosphatase (ALP) measurement in a group of Italian laboratories (2017) (1)
An immunoabsorption assay for bone alkaline phosphatase in serum evaluated (2006) (1)
La importancia de la trazabilidad metrológica en la validez de la medición de creatinina como índice de función renal (2009) (1)
Evaluation of two automated immunoassays for measurement of free deoxypyridinoline in urine using analytical goals derived from biological variation. (1998) (1)
Suitability of the measurement imprecision of commun urinary biochemical analytes (2013) (0)
Elevation of cardiac troponins in patients without overt ischemic heart disease (2003) (0)
Performance of Diagram immunoturbidimetric assay for serum albumin on Abbott Architect c16000 platform (2017) (0)
[Inhibitory action of Hodgkin's disease patients serum on T lymphocytes E rosette forming ability (author's transl)]. (1979) (0)
for Biomarkers of Heart Failure Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical Issues National Academy of Clinical Biochemistry and IFCC Committee for Standardization of (2013) (0)
AACB David Curnow Plenary Lecture - Past Speakers (2011) (0)
Global harmonization in laboratory medicine (2015) (0)
New trends in classification, monitoring and management of cardiovascular diseases (2002) (0)
How can the laboratory help clinicians? The “high-sensitivity” troponin paradigm (2017) (0)
Clinicians at Crossroads for a Dangerous Interference in Neonatal Bilirubin Determination at the Point-of-Care. (2022) (0)
Comparative study of fecal calprotectin (FC) rapid test with the established ELISA method (2011) (0)
Theory and practice of traceable reference intervals (2012) (0)
A clinically relevant monoclonal gammopathy in pediatric age (2013) (0)
Standardization of troponin I measurements : an update 1 ) (2008) (0)
Current approaches for standardization of cardiac troponin I measurements (2009) (0)
Place of troponin in the new ESC/ACC AMI redefinition (2009) (0)
Reference interval for serum folate measured with an assay traceable to the WHO international standard (2017) (0)
On the rate of release of CK isoforms into serum of patients with myocardial infarction treated with thrombolysis. (1989) (0)
Membro dell'Editorial board di Acute cardiac care (2006) (0)
Non-enzymic glycation of apolipoprotein B (APO B) in the sera of diabetic and non-diabetic subjects (1994) (0)
The laboratory investigation of pleural fluids: An update based on the available evidence. (2023) (0)
Lactate dehydrogenase isoenzyme 1 in serum determined by sodium perchlorate inhibition. (1991) (0)
Association between Fasting and Postprandial Levels of Liver Enzymes with Metabolic Syndrome and Suspected Prediabetes in Prepubertal Children (2023) (0)
Catalytic Concentration of Human Creatine Kinase-2 (CK-MB) Determined by IFCC Method at 37°C IRMM/IFCC-455. (2000) (0)
Catalytic Concentration of Alanine Aminotransferase (ALAT) Determined by IFCC Method at 37°C IRMM/IFCC-454. (2000) (0)
An overview of clinical and laboratory issues affecting the laboratory measurement and reporting of troponin (2012) (0)
Catalytic Concentration of Lactate Dehydrogenase Isoenzyme 1 (LD1) Determined by IFCC Method at 37°C IRMM/IFCC-453. (2000) (0)
An unexpectedly prolonged severe hyperbilirubinemia in a patient with pre-existing hepatitis A: a role of genetic predisposition? (2018) (0)
[Can the moderate use of alcohol be considered a protective factor against ischemic cardiopathy?]. (1984) (0)
Allocation of laboratory tests to different models for performance specifications ( TFG-DM ) Criteria for assigning laboratory measurands to models for analytical performance specifications defined in the 1 st EFLM Strategic Conference (2016) (0)
Impact of managing altered results in hemolyzed samples (HS) in an infant-maternity hospital using an unconventional approach (2019) (0)
13.56 Correlation between infarct size and LV ejection fraction in acute myocardial infarct (2001) (0)
Concepts for the standardization of cardiac marker measurements (2008) (0)
Impact of managing affected results in haemolysed samples of an infant-maternity hospital using an unconventional approach. (2021) (0)
Anti-tumour necrosis factor α antibodies and circulating lymphocyte phenotypes in inflammatory bowel disease. (2021) (0)
IFCC Scientific Division , Working Group on Standardization of Glomerular Filtration Rate Assessment ( WG-GFRA ) Prepared for publication by (2006) (0)
BIOCHEMICAL MARKERS AND CARDIAC DISEASES (2003) (0)
Experimental factors influencing selection of decision limits for cardiac troponin (2009) (0)
[An alternative proposal for managing morphological examination of urinary sediment and increasing its appropriateness]. (2018) (0)
EFLM Paper (2017) (0)
Short-term effects of growth hormone on bone metabolism in a patient with mild hunter disease (1998) (0)
Troponin T measured with highly sensitive assay (hsTnT) at admission does not reflect infarct size in ST-elevation myocardial infarction (STEMI) patients (2015) (0)
Measurement of activin A in acute myocardial infarction: is there a clinical role? (2009) (0)
Association of maternal folate and B12 vitamin status with gestational diabetes mellitus: still an open issue. (2023) (0)
A proteolytic method for determination of aspartate aminotransferase isoenzymes in serum evaluated : determination of AST isoenzymes (1992) (0)
Prevalence and clinical significance of enormously increased CA 19.9 concentrations in hospitalised patients (2013) (0)
Recommendations for the clinical use of cardiac natriuretic peptides. (2005) (0)
Standardization in laboratory medicine : activities, goals, and further issues (2008) (0)
Analytical performance of the TOSOH AIA-Pack 2nd-generation car- diac troponin I assay evaluated according to IFCC specifications: A multicenter study (2004) (0)
Evaluation of commutability of the ERM - DA 470k reference material for two albumin assays using immunochemical principles (2011) (0)
Judging the clinical suitability of analytical performance of cardiac troponin assays (2023) (0)
Osteopenia in celiac disease: Does lactose intorance play a major role? (2000) (0)
Table 1. Maximum Rate of Increase per Hour for CK-MM and MB Isoforms into Serum of 20 PatIents with Acute Myocardlal InfarctIon, According to the Presence or Absence of Thrombolytlc Therapy (1989) (0)
Multicenter evaluation of a new liquid formulation for the determination of cholinesterase (2006) (0)
Guidance on Which Calibrators in a Metrologically Traceable Calibration Hierarchy Must Be Commutable with Clinical Samples. (2023) (0)
[The biochemical markers of myocardial damage. The Intersociety Interdisciplinary Study Group of the ANMCO-SIBioC-SIMeL, Markers of Myocardial Lesions. Associazione Nazionale Medici Cardiologi Ospedalieri-SIBioC-Società Italiana di Medicina di Laboratorio]. (1999) (0)
Membro dell'Editorial board di Clinica chimica acta (2004) (0)
ORIGINAL ARTICLE Enzymatic assays for creatinine: Time for action (2008) (0)
Biological variation in urinary excretion of deoxypyridoline (2006) (0)
underpins medicine : the “ high-sensitivity ” troponin paradigm (2015) (0)
Validation of "Outcome-Based" Pediatric Critical Value Threshold for Plasma Glucose in an Infant and Maternity Hospital Setting. (2020) (0)
Suitability of icteric index as front-line test for the identification of blood samples with abnormal bilirubin concentrations (2015) (0)
PO27 A CASE OF MONOCLONAL GAMMOPATHY IN PEDIATRIC CROHN'S DISEASE (2012) (0)
Models 1b and 2 according to EFLM consensus conference give the same specification for allowable total error (TEA) of plasma glucose measurement (2017) (0)
Diagnostic value of N-terminal ProB-Type Natriuretic Peptide in Emergency Department: Analysis by subgroups (2012) (0)
Markers of Kidney Disease: 11th Bergmeyer Conference, IFCC-Roche Diagnostics Master Discussion, Improving the Clinical Value of Laboratory Data. Foreword. (2008) (0)
C-reactive protein and clinical outcome in COVID-19 patients: the importance of harmonized measurements (2023) (0)
Reply to La Gioia: effects of cold agglutinins on the automated complete blood count accuracy (2021) (0)
Foreword (2008) (0)
The new multidisciplinary paradigm for fatty liver disease should also include the laboratory medicine contribution (2021) (0)
Impact of implementation of the new highly sensitive cardiac troponin T (hsTnT) assay in a university hospital setting (2011) (0)
Update on the biochemistry and clinical utility of cardiac markers (2009) (0)
Development and Validation of a Laboratory Score Based on Blood Cell Parameters to Predict Survival in Hospitalized COVID-19 Patients (2020) (0)
Standardization and analytical goals for glycated hemoglobin measurement (2014) (0)
New insights in the pathophysiology of acute myocardial infarction (MI) detectable by a new generation Troponin I assay (2013) (0)
Point/Counterpoint: Put Simply - Standardization of Cardiac Troponin I is Complicated | NIST (2011) (0)
La misura delle proteine totali per la quantificazione del crioprecipitato è “evidence-based”? = Is the total protein measurement for cryocrit quantification evidence-based? (2014) (0)
Commutability of widely adopted reference material CRM 470 is still an issue for ceruloplasmin assays (2009) (0)
Diagnostic Value of Prostatic Acid Phosphatase (Pap) and Prostate-Specific Antigen (Psa) in Patients with Prostatic Cancer (1992) (0)
Cardiac troponin I elevation in serum as a marker of right ventricular involvement and disease severity in acute pulmonary embolism (2001) (0)
Increase in body mass index (BMI) does not decrease human epididymis protein 4 (HE4) concentrations in serum (2015) (0)
Improving D-dimer appropriateness by controlling periodicity of retesting: Prevention is better than cure (2019) (0)
Poster display II, clinical general and PET/CT4.21: Left ventricular remodelling after a myocardial infarction investigated by gated SPECT (2007) (0)
[The role of biochemical markers of myocardial damage in clinical practice: the diagnosis of infarct and risk stratification. The Intersociety Interdisciplinary Study Group of the ANMCO-SIBioC-SIMeL, Markers of Muocardial Lesions. L'Associazione Nazionale Medici Cardiologi Ospedalieri-Società Italia (2000) (0)
Reflex Testing of Free Prostate-Specific Antigen as Effective Health Care Policy. (2019) (0)
13.58 Determination of infaret size: sestamibi SPECT versus biochemical evaluation (2001) (0)
Anemia acquisita da ospedalizzazione : il ruolo delle perdite di sangue a scopo diagnostico [Hospital-acquired anemia: the role of diagnostic blood loss] (2017) (0)
Troponin T measured with highly sensitive assay (hsTnT) on admission does not reflect infarct size in ST-elevation myocardial infarction patients receiving primary percutaneous coronary intervention (2015) (0)
Validation of hemoglobin and hematocrit measurements on GEM Premier 4000 blood gas analyzer (2016) (0)
Final considerations (2008) (0)
Clinical Pathology of Pancreatic Disorders. (1998) (0)
Measurement Uncertainty of Thyroid Function Tests on a Chemiluminescent Microparticle Immunoassay System Needs to Be Improved. (2023) (0)
Laboratory Community Should Be More Proactive in Highlighting the Negative Impact of Analytical Non-Selectivity of Some Creatinine Assays. (2022) (0)
Applications et futur de la spectrométrie de masse en médecine de laboratoire (2015) (0)
La importancia de la trazabilidad metrológica en la validez de la medición (2009) (0)
The basics of biomarker interpretation (2006) (0)
Is there a role for procalcitonin determination in avoiding unnecessary exposure to antibiotics in a non-intensive care setting? (2019) (0)
TimeCourseof Changesin Pancreatic Enzymes,Isoenzymes, andIsoforms in SerumafterEndoscopic Retrograde Cholangiopancreatography (1991) (0)
Haematological and inflammatory effects of short-term exposure to urban particulate matter: The PM-CARE study (2006) (0)
Time Course of Changes in PancreaticEnzymes , Isoenzymes , and Isoformsin Serum after EndoscopicRetrogradeCholangiopancreatography (2004) (0)
Benign Inherited Hyperphosphatasemiaof IntestinalOrigin: Report of Two Cases and a Brief Review of the Literature (1991) (0)
HbA1c : IFCC standardization (2010) (0)
Recommendations for assessing commutability part 2: based on the difference in bias between a reference material and clinical samples (2018) (0)
Membro dell'Editorial board di Clinical chemistry and laboratory medicine (2009) (0)
Foreword (2010) (0)
Optimizing order entry presentation: a simple tool to help decrease redundancy in coagulation testing. (2023) (0)
Selective measurement of mitochondrial aspartate aminotransferase in serum with use of proteinase K (1993) (0)
IMPACT OF TRACEABILITY CONCEPT IN LABORATORY MEDICINE (2008) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Mauro Panteghini?

Mauro Panteghini is affiliated with the following schools:

Mauro Panteghini's Academic­Influence.com Rankings

Mauro Panteghini's Degrees

Similar Degrees You Can Earn

Why Is Mauro Panteghini Influential?

Mauro Panteghini's Published Works

Published Works

What Schools Are Affiliated With Mauro Panteghini?

Mauro Panteghini's AcademicInfluence.com Rankings